SHAFF ERIC D. (See Remarks) sold 6.2% of their position (12.73K shares) of SERES THERAPEUTICS, INC. on the open market
Open‑market sale worth $10.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/19/2025ACC: 0000950170-25-023575
Officer· See Remarks
Since Jan 2019
-12.73K
Net shares
Net seller
$10.3K
Total sold
1
Open market trades
0B · 1S
5
Total transactions
34.38K acquired · 47.10K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+7.81K
Price / share
—
Trade value
—
% of position
4.6%
2/15/2025
170.39K→178.20K
Common Stock
Direct
Shares
+26.56K
Price / share
—
Trade value
—
% of position
14.9%
2/15/2025
178.20K→204.76K
Common Stock
Direct
Shares
−12.73K
Price / share
$0.81
Trade value
$10.31K
% of position
6.2%
2/18/2025
204.76K→192.04K
Total
Net shares
+21.65K
Net value
-$10.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/15/2025 | M · Option Exercise | +7.81K | — | — | 4.6% | 170.39K | 178.20K |
| Common Stock Direct | 2/15/2025 | M · Option Exercise | +26.56K | — | — | 14.9% | 178.20K | 204.76K |
| Common Stock Direct | 2/18/2025 | S · Sale | −12.73K | $0.81 | $10.31K | 6.2% | 204.76K | 192.04K |
| Total | +21.65K | -$10.31K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
7.81K shares
Shares
−7.81K
Strike price
Held after
62.50K
Exercisable
—
2/15/2025
Restricted Stock Units
Direct
Converts to
Common Stock
26.56K shares
Shares
−26.56K
Strike price
Held after
79.69K
Exercisable
—
2/15/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock7.81K shares | 2/15/2025 | M · Option Exercise | −7.81K | — | 62.50K | |
| Restricted Stock Units Direct | Common Stock26.56K shares | 2/15/2025 | M · Option Exercise | −26.56K | — | 79.69K |